1Vision Biogas announces outcome of the extended acceptance period of the mandatory cash offer to the shareholders of Biokraft
The Offer is not being made, and this press release may not be released, distributed or published, in whole or in part, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in, the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa, South Korea, Russia, Belarus or any other jurisdiction in which the making of the Offer, the release, distribution or publication of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law. Other restrictions apply. Please refer to the “Important information” at the end of this press release.
Press release
28 March 2024
1Vision Biogas announces outcome of the extended acceptance period of the mandatory cash offer to the shareholders of Biokraft
On 2 February 2024, 1Vision Biogas AB (“1Vision Biogas”) announced a mandatory offer to the shareholders of Biokraft International AB (“Biokraft”) to acquire all shares in Biokraft at a price of SEK 20.65 in cash per share (the “Offer”). Biokraft’s shares are listed on Nasdaq First North Premier Growth Market. An offer document regarding the Offer was published on 2 February 2024 and supplemented on 7 February 2024, with an additional supplement on 27 February 2024. On 15 February 2024, 1Vision Biogas announced that the necessary regulatory approvals for completion of the Offer had been obtained. The initial acceptance period expired on 11 March 2024.
As of the date of the announcement of the Offer, 1Vision Biogas held 23,977,232 shares in Biokraft, corresponding to approximately 55.0 per cent of the total number of shares and votes in Biokraft.
On 13 March 2024, 1Vision Biogas announced that the Offer had been accepted by shareholders holding in total 17,521,047 shares in Biokraft, corresponding to approximately 40.2 per cent of the total number of shares and votes in Biokraft. As a result, 1Vision Biogas controlled 41,498,279 shares in Biokraft in total, corresponding to approximately 95.2 per cent of the total number of shares and votes in Biokraft, and extended the acceptance period.
During the extended acceptance period, which expired on 27 March 2024, the Offer has been accepted by shareholders with a total of 694,047 shares in Biokraft, corresponding to approximately 1.6 per cent of the total number of shares and votes in Biokraft. After the end of the extended acceptance period, 1Vision Biogas thus controls 42,192,326 shares in Biokraft in total, corresponding to approximately 96.8 per cent of the total number of shares and votes in Biokraft.
Settlement in respect of shares tendered during the extended acceptance period will begin on or around 4 April 2024. 1Vision Biogas will not further extend the acceptance period for the Offer.
Neither 1Vision Biogas nor any closely related party to 1Vision Biogas have acquired shares or financial instruments that give a financial exposure equivalent to a shareholding in Biokraft outside of the Offer.
1Vision Biogas has initiated a compulsory acquisition of the remaining shares in Biokraft in accordance with the Swedish Companies Act. In connection therewith, the board of Biokraft, following a request from 1Vision Biogas, has decided to apply for delisting of the Biokraft share from Nasdaq First North Premier Growth Market. On 26 March 2024, Biokraft announced that Nasdaq had approved Biokraft’s application for delisting and resolved that the last day of trading in Biokraft’s share on Nasdaq First North Premier Growth Market will be 8 April 2024.
1Vision Biogas has engaged Danske Bank A/S, Danmark, Sverige Filial as financial adviser and Vinge as legal adviser in connection with the Offer.
Additional information about the Offer is available at www.1visionbiogas.se.
_______________
Further information
For further information, please contact:
Henrikki Talvitie, Chairman of the board of 1Vision Biogas, CEO St1 Nordic Oy,
Henrikki.Talvitie@st1.com
Jan Harald Solstad, member of the board of 1Vision Biogas, Senior Partner HitecVision
Jan.Harald.Solstad@hitecvision.com
This information was submitted for publication on 28 March 2024 at 16:25 CET.
Important information
The Offer is not being made to persons whose participation in the Offer requires that additional offer documents be prepared or registrations effected or that any other measures be taken in addition to those required under Swedish law.
The distribution of this press release and any related offer documentation in certain jurisdictions may be restricted or affected by the laws of such jurisdictions. Accordingly, copies of this communication are not being, and must not be, mailed or otherwise forwarded, distributed or sent in, into or from any such jurisdiction. Therefore, persons who receive this communication (including, without limitation, nominees, trustees and custodians) and are subject to the laws of any such jurisdiction will need to inform themselves about, and observe, any applicable restrictions or requirements. Any failure to do so may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, 1Vision Biogas disclaims any responsibility or liability for the violations of any such restrictions by any person.
The Offer is not being made, and this press release may not be released, distributed or published, in whole or in part, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in, the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa, South Korea, Russia, Belarus or any other jurisdiction in which the making of the Offer, the release, distribution or publication of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law.
The Offer, the information and documents contained in this press release are not being made and have not been approved by an authorised person for the purposes of section 21 of the UK Financial Services and Markets Act 2000 (the “FSMA”). Accordingly, the information and documents contained in this press release are not being distributed to, and must not be passed on to, the general public in the United Kingdom, unless an exemption applies. The communication of the information and documents contained in this press release is exempt from the restriction on financial promotions under section 21 of the FSMA on the basis that it is a communication by or on behalf of a body corporate which relates to a transaction to acquire day to day control of the affairs of a body corporate; or to acquire 50 per cent or more of the voting shares in a body corporate, within article 62 of the UK Financial Services and Markets Act 2000 (Financial Promotion) Order 2005.
Statements in this press release relating to future status or circumstances, including statements regarding future performance, growth and other trend projections and the other benefits of the Offer, are forward-looking statements. These statements may generally, but not always, be identified by the use of words such as “anticipates”, “intends”, “expects”, “believes”, or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside the control of 1Vision Biogas and Biokraft. Any such forward-looking statements speak only as of the date on which they are made and 1Vision Biogas has no obligation (and undertakes no such obligation) to update or revise any of them, whether as a result of new information, future events or otherwise, except for in accordance with applicable laws and regulations.